Diagnostic Accuracy of Cerebrospinal Fluid (CSF) Cytology in Metastatic Tumors: An Analysis of Consecutive CSF Samples
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Cerebrospinal fluid (CSF) examination can be used to verify the presence of primary malignancies as well as cases of central nervous system (CNS) metastasis. Because of its importance,there have been several studies concerning the sensitivity of CSF cytology. To determine the practical use and reproducibility of diagnoses based on CSF cytology, we evaluated this test by analyzing cytology results from consecutive CSF samples. Methods: Between July 2010 and June 2013, 385 CSF cytology samples from 42 patients were collected. The samples were gathered using a ventricular catheter and reservoir. CSF cytology of all patients was examined more than two times with immunocytochemistry for cytokeratin. Results: Primary neoplastic sites and histologic types of patients’ metastatic cancer were diverse. The overall sensitivity for detecting malignancy was 41.3%. Even within short-term intervals, diagnoses frequently changed. Conclusions: Our results were inconsistent, with low sensitivity, when compared to the results of previous studies. However, CSF evaluation can still provide valuable diagnostic and prognostic information because adjuvant treatments are now routinely performed in patients with CNS metastasis. Negative CSF cytology results should not be ignored, and continuous CSF follow-up is essential for following the clinical course of patients with metastatic cancer involving the CNS.
Abstract
Background: Cerebrospinal fluid (CSF) examination can be used to verify the presence of primary malignancies as well as cases of central nervous system (CNS) metastasis. Because of its importance,there have been several studies concerning the sensitivity of CSF cytology. To determine the practical use and reproducibility of diagnoses based on CSF cytology, we evaluated this test by analyzing cytology results from consecutive CSF samples. Methods: Between July 2010 and June 2013, 385 CSF cytology samples from 42 patients were collected. The samples were gathered using a ventricular catheter and reservoir. CSF cytology of all patients was examined more than two times with immunocytochemistry for cytokeratin. Results: Primary neoplastic sites and histologic types of patients’ metastatic cancer were diverse. The overall sensitivity for detecting malignancy was 41.3%. Even within short-term intervals, diagnoses frequently changed. Conclusions: Our results were inconsistent, with low sensitivity, when compared to the results of previous studies. However, CSF evaluation can still provide valuable diagnostic and prognostic information because adjuvant treatments are now routinely performed in patients with CNS metastasis. Negative CSF cytology results should not be ignored, and continuous CSF follow-up is essential for following the clinical course of patients with metastatic cancer involving the CNS.
참고문헌 (17)
- Savage NM, "The cytologic findings in choroid plexus carcinoma: report of a case with differential diagnosis", Diagn Cytopathol, 40, pp.1~6 (2012)
- Aboulafia DM, "Carcinomatous meningitis complicating cervical cancer: a clinicopathologic study and literature review", Gynecol Oncol, 60, pp.313~318 (1996)
- Glosová L, "Gallbladder carcinoma cells in cerebrospinal fluid as the first manifestation of a tumor: a case report", Acta Cytol, 47, pp.1087~1090 (2003)
- Glass JP, "Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology", Neurology, 29, pp.1369~1375 (1979)
- Wasserstrom WR, "Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients", Cancer, 49, pp.759~772 (1982)
- Gondos B, "Cerebrospinal fluid cytology: diagnostic accuracy and comparison of different techniques", Acta Cytol, 20, pp.542~547 (1976)
- Chowdhary S, "Leptomeningeal metastases: current concepts and management guidelines", J Natl Compr Canc Netw, 3, pp.693~703 (2005)
- Scurry JP, "Thin layer compared to direct smear in thyroid fine needle aspiration", Cytopathology, 11, pp.104~115 (2000)
- Frost AR, "Utility of thin-layer preparations in thyroid fine-needle aspiration: diagnostic accuracy, cytomorphology, and optimal sample preparation", Cancer, 84, pp.17~25 (1998)
- Linder J, "Recent advances in thin-layer cytology", Diagn Cytopathol, 18, pp.24~32 (1998)
- Leung CS, "Comparison of ThinPrep and conventional preparations: nongynecologic cytology evaluation", Diagn Cytopathol, 16, pp.368~371 (1997)
- Argon A, "The effectiveness of the liquid-based preparation method in cerebrospinal fluid cytology", Acta Cytol, 57, pp.266~270 (2013)
- Sioutopoulou DO, "Diagnosis of metastatic tumors in cerebrospinal fluid samples using thin-layer cytology", Acta Cytol, 52, pp.304~308 (2008)
- Schinstine M, "Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious", Cancer, 108, pp.157~162 (2006)
- Fadda G, "Diagnostic efficacy of immunocytochemistry on fine needle aspiration biopsies processed by thin-layer cytology", Acta Cytol, 50, pp.129~135 (2006)
- Dabbs DJ, "Immunocytochemistry on the Thinprep processor", Diagn Cytopathol, 17, pp.388~392 (1997)
- Leung SW, "Immunocytochemical staining on ThinPrep processed smears", Mod Pathol, 9, pp.304~306 (1996)